Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIV.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
10 2023
Historique:
revised: 23 07 2023
received: 06 06 2023
accepted: 25 07 2023
medline: 2 10 2023
pubmed: 26 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

Here, we provide the first regional analysis of intact and defective HIV reservoirs within the brain. Brain tissue from both viremic and virally suppressed people with HIV (PWH) harbored HIV pol DNA in all regions tested, with lower levels present in basal ganglia and cerebellum relative to frontal white matter. Intact proviruses were primarily found in the frontal white matter but also detected in other brain regions of PWH, demonstrating frontal white matter as a major brain reservoir of intact, potentially replication competent HIV DNA that persists despite antiretroviral therapy. ANN NEUROL 2023;94:798-802.

Identifiants

pubmed: 37493435
doi: 10.1002/ana.26750
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

798-802

Subventions

Organisme : NIDA NIH HHS
ID : R21 DA055489
Pays : United States

Informations de copyright

© 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Churchill MJ, Wesselingh SL, Cowley D, et al. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 2009;66:253-258.
Cho HJ, Bertrand L, Toborek M. Blood-brain barrier pericytes as a target for HIV-1 infection. Brain 2019;142:502-511.
Cochrane CR, Angelovich TA, Byrnes SJ, et al. Intact HIV proviruses persist in the brain despite viral suppression with ART. Ann Neurol 2022;92:532-544.
Lamers SL, Rose R, Maidji E, et al. HIV DNA is frequently present within pathologic tissues evaluated at autopsy from cART-treated patients with undetectable viral load. J Virol 2016;90:8968-8983.
Melrose RJ, Tinaz S, Castelo JMB, et al. Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav Brain Res 2008;188:337-347.
Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011;17:3-16.
Perez S, Johnson A-M, Xiang SH, et al. Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy. J Neurovirol 2018;24:62-74.
Zhou L, Rua R, Ng T, et al. Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementia. BMC Infect Dis 2009;9:192.
Morgello S, Gelman BB, Kozlowski PB, et al. The national NeuroAIDS tissue consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 2001;27:326-335.
Strain MC, Lada SM, Luong T, et al. Highly precise measurement of HIV DNA by droplet digital PCR. PloS One 2013;8:e55943.
Bruner KM, Wang Z, Simonetti FR, et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 2019;566:120-125.
Sei S, Saito K, Stewart SK, et al. Increased human immunodeficiency virus (HIV) type 1 DNA content and Quinolinic acid concentration in brain tissues from patients with HIV encephalopathy. J Infect Dis 1995;172:638-647.
Fujimura RK, Goodkin K, Petito CK, et al. HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:146-152.
Oliveira MF, Pankow A, Vollbrecht T, et al. Evaluation of archival HIV DNA in brain and lymphoid tissues. J Virol 2023;97:e0054323.
Ferrara M, Bumpus NN, Ma Q, et al. Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS 2020;34:1907-1914.
Tan YL, Yuan Y, Tian L. Microglial regional heterogeneity and its role in the brain. Mol Psychiatry 2020;25:351-367.
Bruner KM, Murray AJ, Pollack RA, et al. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med 2016;22:1043-1049.
Gabuzda D, Yin J, Misra V, et al. Intact Proviral DNA analysis of the brain viral reservoir and relationship to Neuroinflammation in people with HIV on suppressive antiretroviral therapy. Viruses 2023;15:1009.
Imamichi H, Smith M, Adelsberger JW, et al. Defective HIV-1 proviruses produce viral proteins. Proc Natl Acad Sci U S A 2020;117:3704-3710.
Pollack RA, Jones RB, Pertea M, et al. Defective HIV-1 proviruses are expressed and can Be recognized by cytotoxic T lymphocytes, which shape the Proviral landscape. Cell Host Microbe 2017;21:494-506.e4.
Tang Y, Chaillon A, Gianella S, et al. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy. J Clin Invest 2023;133:e167417.

Auteurs

Thomas A Angelovich (TA)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.
Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia.
Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Catherine R Cochrane (CR)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.
Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.

Jingling Zhou (J)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.

Carolin Tumpach (C)

Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Sarah J Byrnes (SJ)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.

Janna Jamal Eddine (J)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.

Emily Waring (E)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.

Kathleen Busman-Sahay (K)

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Hillsboro, Oregon, USA.

Claire Deleage (C)

AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.

Trisha A Jenkins (TA)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.

Anna C Hearps (AC)

Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Stuart Turville (S)

The Kirby Institute, University of New South Wales, Kensington, New South Wales, Australia.

Paul R Gorry (PR)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.

Sharon R Lewin (SR)

Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Bruce J Brew (BJ)

Peter Duncan Neurosciences Unit, Departments of Neurology and Immunology St. Vincent's Hospital, University of New South Wales, Sydney, New South Wales, Australia.
University of Notre Dame, Sydney, New South Wales, Australia.

Jacob D Estes (JD)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.
Vaccine and Gene Therapy Institute, Oregon Health & Science University, Hillsboro, Oregon, USA.

Michael Roche (M)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.
Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Melissa J Churchill (MJ)

Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.
Life Sciences Discipline, Burnet Institute, Melbourne, Victoria, Australia.
Departments of Microbiology and Medicine, Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH